Uranium Royalty’s (UROY) Buy Rating Reiterated at HC Wainwright

Uranium Royalty (NASDAQ:UROY – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $4.50 target price on the stock. HC Wainwright’s price objective would indicate a potential upside of 26.94% from the company’s previous close.

Other equities research analysts also recently issued reports about the company. Weiss Ratings raised Uranium Royalty from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Zacks Research downgraded Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Finally, National Bank Financial started coverage on shares of Uranium Royalty in a research note on Wednesday, July 29th. They set an “outperform” rating and a $3.75 price target on the stock. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $4.13.

Get Our Latest Research Report on UROY

Uranium Royalty Stock Up 0.1%

Shares of NASDAQ:UROY traded up $0.01 during trading on Monday, reaching $3.55. 673,191 shares of the company traded hands, compared to its average volume of 2,960,050. The firm has a fifty day simple moving average of $4.21 and a 200 day simple moving average of $3.65. The firm has a market cap of $1.34 billion, a P/E ratio of 39.39 and a beta of 1.57. Uranium Royalty has a 1-year low of $2.56 and a 1-year high of $5.52. The company has a quick ratio of 0.87, a current ratio of 0.88 and a debt-to-equity ratio of 0.49.

Uranium Royalty (NASDAQ:UROY – Get Free Report) last issued its earnings results on Monday, September 14th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.05. The company had revenue of $51.68 million during the quarter, compared to analyst estimates of $52.23 million. Uranium Royalty had a net margin of 25.88% and a return on equity of 10.86%. Analysts anticipate that Uranium Royalty will post 0.11 earnings per share for the current fiscal year.

Institutional Trading of Uranium Royalty

Several large investors have recently made changes to their positions in UROY. Quantbot Technologies LP bought a new stake in shares of Uranium Royalty during the 2nd quarter worth about $421,000. The Manufacturers Life Insurance Company bought a new stake in shares of Uranium Royalty during the 2nd quarter worth about $402,000. Squarepoint Ops LLC bought a new stake in shares of Uranium Royalty during the 2nd quarter worth about $397,000. Renaissance Technologies LLC boosted its stake in shares of Uranium Royalty by 206.5% during the 1st quarter. Renaissance Technologies LLC now owns 196,751 shares of the company’s stock worth $718,000 after acquiring an additional 132,551 shares in the last quarter. Finally, BlackRock Inc. bought a new stake in shares of Uranium Royalty during the 2nd quarter worth about $227,000. Institutional investors own 24.19% of the company’s stock.

Uranium Royalty Company Profile

(Get Free Report)

Uranium Royalty Corp. (NASDAQ: UROY) is a uranium-focused royalty and streaming company. It seeks exposure to the uranium sector through a portfolio of royalties, streams, debt and equity investments in uranium projects, as well as holdings of physical uranium. The company does not primarily operate mines; instead, its business model is designed to provide participation in uranium production and prices without directly bearing the full costs of mine development and operation.

Its interests are tied to uranium projects and properties in established producing and prospective regions, including Canada, the United States and Australia.

See Also

Analyst Recommendations for Uranium Royalty (NASDAQ:UROY)

Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.